These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3126703)

  • 21. In vitro activity of ampicillin/sulbactam against enterococci determined by the time-kill method.
    D'Amato RF; Mathew A; Hochstein L; Cleri DJ; Johnson J
    Diagn Microbiol Infect Dis; 1989; 12(1):9-11. PubMed ID: 2496949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis.
    Rice LB; Eliopoulos GM; Wennersten C; Goldmann D; Jacoby GA; Moellering RC
    Antimicrob Agents Chemother; 1991 Feb; 35(2):272-6. PubMed ID: 1902647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.
    Kitzis MD; Billot-Klein D; Goldstein FW; Williamson R; Tran Van Nhieu G; Carlet J; Acar JF; Gutmann L
    Antimicrob Agents Chemother; 1988 Jan; 32(1):9-14. PubMed ID: 2831817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis.
    Wells VD; Wong ES; Murray BE; Coudron PE; Williams DS; Markowitz SM
    Ann Intern Med; 1992 Feb; 116(4):285-92. PubMed ID: 1733382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
    Arias CA; Singh KV; Panesso D; Murray BE
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci.
    Zervos MJ; Patterson JE; Edberg S; Pierson C; Kauffman CA; Mikesell TS; Schaberg DR
    J Clin Microbiol; 1987 Dec; 25(12):2443-4. PubMed ID: 3123515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D; Simonet M; Veron M
    Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Prevalence of the
    Costa LBD; Corá LF; Correa FEL; Gabrielli LC; de Oliveira MR; Conceição N; Oliveira AG
    Microb Drug Resist; 2019 Nov; 25(9):1275-1281. PubMed ID: 31361553
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis.
    Markowitz SM; Wells VD; Williams DS; Stuart CG; Coudron PE; Wong ES
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1075-80. PubMed ID: 1929246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci.
    Chen HY; Williams JD
    J Antimicrob Chemother; 1983 Jul; 12(1):19-26. PubMed ID: 6413484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.
    Jones RN
    Drugs; 1988; 35 Suppl 7():17-26. PubMed ID: 3265377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
    Sánchez Valenzuela A; Lavilla Lerma L; Benomar N; Gálvez A; Pérez Pulido R; Abriouel H
    Foodborne Pathog Dis; 2013 Feb; 10(2):143-9. PubMed ID: 23259502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.
    Zinner SH; Gilbert D; Dudley MN
    Antimicrob Agents Chemother; 1998 Jan; 42(1):72-7. PubMed ID: 9449263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms.
    Singh KV; Coque TM; Murray BE
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2142-6. PubMed ID: 8878596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.
    Cercenado E; Eliopoulos GM; Wennersten CB; Moellering RC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2526-8. PubMed ID: 1489198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.